Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunosuppression and vaccinations].

D Débat Zoguéreh1, J M Ruiz

  • 1Faculté des sciences de la santé, Bangui, République centrafricaine.debzog@caramail.com

Sante (Montrouge, France)
|October 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cascading ecological impacts: from eutrophic coastal lagoon collapse to decline of Posidonia oceanica meadows in the Mediterranean.

Marine pollution bulletin·2025
Same author

Binder-free all-carbon composite supercapacitors.

Nanotechnology·2024
Same author

Photo-acclimatory thresholds anticipate sudden shifts in seagrass ecosystem state under reduced light conditions.

Marine environmental research·2022
Same author

Positive effects of high salinity can buffer the negative effects of experimental warming on functional traits of the seagrass Halophila ovalis.

Marine pollution bulletin·2020
Same author

Influence of the proline metabolism and glycine betaine on tolerance to salt stress in tomato (Solanum lycopersicum L.) commercial genotypes.

Journal of plant physiology·2018
Same author

Carbon economy of Mediterranean seagrasses in response to thermal stress.

Marine pollution bulletin·2018
Same journal

[Cannabis use in a central region of Tunisia].

Sante (Montrouge, France)·2012
Same journal

[Factors associated with overweight and obesity in children in Ouagadougou (Burkina Faso)].

Sante (Montrouge, France)·2012
Same journal

[Epidemiology, microbiology, and outcomes of septicemia in children treated at the Charles de Gaulle University Pediatric Hospital in Burkina Faso].

Sante (Montrouge, France)·2012
Same journal

[Medical audit of neonatal deaths with the "three delay" model in a pediatric hospital in Ouagadougou].

Sante (Montrouge, France)·2012
Same journal

[Controlling caesarean-site infection. Collaboration between the obstetric and hospital hygiene departments].

Sante (Montrouge, France)·2012
Same journal

[Sickle cell disease is one century old: what about therapeutics?].

Sante (Montrouge, France)·2012
See all related articles

Vaccination is crucial for immunocompromised individuals to prevent infections. Live vaccines are generally not recommended due to risks, while inactivated vaccines are preferred for managing infectious diseases in these patients.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Immunocompromised individuals face elevated infection risks.
  • Vaccination offers a preventative strategy against certain infections when curative treatments are lacking.
  • The type and severity of immunodeficiency dictate specific vaccine recommendations.

Purpose of the Study:

  • To outline vaccination strategies for immunocompromised populations.
  • To differentiate between recommended and contraindicated vaccines based on immunodeficiency status.
  • To address vaccination needs in the context of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS).

Main Methods:

  • Review of existing literature and guidelines on vaccinating immunocompromised patients.

Related Experiment Videos

  • Analysis of vaccine types (live vs. inactivated) and their safety profiles.
  • Consideration of specific patient populations, including those with HIV/AIDS.

    • Main Results:

    • Inactivated vaccines are generally indicated for immunocompromised individuals.
    • Live vaccines pose risks, including uncontrolled infection, increased viral replication (especially in HIV+ subjects), and poor immune response.
    • Vaccination against common childhood diseases is advisable for HIV-infected individuals, adjusted for contagion risk and immunodeficiency level.

    Conclusions:

    • Vaccination strategies must be tailored to the individual's immune status.
    • Inactivated vaccines are the preferred choice for immunocompromised patients.
    • Live vaccines should generally be avoided in immunocompromised individuals due to safety concerns.